Title : Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway.

Pub. Date : 2017 Mar

PMID : 28349827






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway. Staurosporine AKT serine/threonine kinase 1 Homo sapiens
2 We found that staurosporine significantly decreased cell viability and increased cell apoptosis in a concentration- and time-dependent manner in HepG2 cancer cells, along with the decreased expressions of PDK1 protein and Akt phosphorylation. Staurosporine AKT serine/threonine kinase 1 Homo sapiens
3 Taken together, our results indicate that staurosporine induced cytotoxicity response by inhibiting PI3K/Akt signaling pathway through Omi/HtrA2-mediated PDK1 degradation, and the process provides a novel mechanism by which staurosporine produces its therapeutic effects. Staurosporine AKT serine/threonine kinase 1 Homo sapiens
4 Taken together, our results indicate that staurosporine induced cytotoxicity response by inhibiting PI3K/Akt signaling pathway through Omi/HtrA2-mediated PDK1 degradation, and the process provides a novel mechanism by which staurosporine produces its therapeutic effects. Staurosporine AKT serine/threonine kinase 1 Homo sapiens